ARTICLE | Financial News
TVM closes Fund VII at $201.6M
October 7, 2014 2:24 AM UTC
TVM Capital Life Science announced the final closing of its TVM Life Science Ventures VII at $201.6 million.
Lead investors included Teralys Capital and Eli Lilly and Co. (NYSE:LLY). Also participating were Business Development Bank of Canada, Minnesota Life Insurance Company, CD Venture, FondAction, Bukwang Pharmaceutical Co. Ltd. (Seoul, South Korea) and an undisclosed pharmaceutical company. ...